WikiPathways:NewPathwayReleases
From WikiPathways
(Difference between revisions)
(June release) |
(July update) |
||
| Line 1: | Line 1: | ||
'''Each month there are new pathways reviewed and approved for the official release of WikiPathways. See the [[Download_Pathways|Download Page]] to access the full collection.''' | '''Each month there are new pathways reviewed and approved for the official release of WikiPathways. See the [[Download_Pathways|Download Page]] to access the full collection.''' | ||
| + | ===July 2021=== | ||
| + | {| style="margin: 10px; background-color:#E4EEF2" | ||
| + | |width=100px|{{#pwImage:Pathway:WP5023|250px||Hypoxia-dependent self-renewal of myoblasts (Mus musculus)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5024|250px||Hypoxia-dependent proliferation of myoblasts (Mus musculus)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5025|250px||Hypoxia-dependent differentiation of myoblasts (Mus musculus)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5120|250px||Inclusion body myositis (Homo sapiens)}} | ||
| + | |- | ||
| + | |width=100px|{{#pwImage:Pathway:WP5108|250px||Familial hyperlipidemia type 1 (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5109|250px||Familial hyperlipidemia type 2 (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5110|250px||Familial hyperlipidemia type 3 (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5111|250px||Familial hyperlipidemia type 4 (Homo sapiens)}} | ||
| + | |- | ||
| + | |width=100px|{{#pwImage:Pathway:WP5098|250px||T-cell activation SARS-CoV-2 (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5101|250px||Congenital generalized lipodystrophy (CGL) (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5102|250px||Familial partial lipodystrophy (FPLD) (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5103|250px||Progeria-associated lipodystrophy (Homo sapiens)}} | ||
| + | |- | ||
| + | |width=100px|{{#pwImage:Pathway:WP5112|250px||Familial hyperlipidemia type 5 (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5104|250px||Acquired partial lipodystrophy / Barraquer-Simons syndrome (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5113|250px||Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5124|250px||Alzheimer's disease (Homo sapiens)}} | ||
| + | |- | ||
| + | |width=100px|{{#pwImage:Pathway:WP5116|250px||SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5105|250px||Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia (Homo sapiens)}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP5092|250px||Interactions of natural killer cells in pancreatic cancer (Homo sapiens)}} | ||
| + | |} | ||
===June 2021=== | ===June 2021=== | ||
{| style="margin: 10px; background-color:#E4EEF2" | {| style="margin: 10px; background-color:#E4EEF2" | ||
Revision as of 00:15, 13 July 2021
Each month there are new pathways reviewed and approved for the official release of WikiPathways. See the Download Page to access the full collection.
Contents |
July 2021
|
Image does not exist Hypoxia-dependent self-renewal of myoblasts (Mus musculus) |
Image does not exist Hypoxia-dependent proliferation of myoblasts (Mus musculus) |
Image does not exist Hypoxia-dependent differentiation of myoblasts (Mus musculus) |
Image does not exist Inclusion body myositis (Homo sapiens) |
|
Image does not exist Familial hyperlipidemia type 1 (Homo sapiens) |
Image does not exist Familial hyperlipidemia type 2 (Homo sapiens) |
Image does not exist Familial hyperlipidemia type 3 (Homo sapiens) |
Image does not exist Familial hyperlipidemia type 4 (Homo sapiens) |
|
Image does not exist T-cell activation SARS-CoV-2 (Homo sapiens) |
Image does not exist Congenital generalized lipodystrophy (CGL) (Homo sapiens) |
Image does not exist Familial partial lipodystrophy (FPLD) (Homo sapiens) |
Image does not exist Progeria-associated lipodystrophy (Homo sapiens) |
|
Image does not exist Familial hyperlipidemia type 5 (Homo sapiens) |
Image does not exist Acquired partial lipodystrophy / Barraquer-Simons syndrome (Homo sapiens) |
Image does not exist Antiviral and anti-inflammatory effects of Nrf2 on SARS-CoV-2 pathway (Homo sapiens) |
Image does not exist Alzheimer's disease (Homo sapiens) |
|
Image does not exist SARS-CoV-2 B.1.1.7 variant antagonises innate immune activation (Homo sapiens) |
Image does not exist Meta pathway lipodystrophy, dyslipidemia and hyperlipidemia (Homo sapiens) |
Image does not exist Interactions of natural killer cells in pancreatic cancer (Homo sapiens) |
June 2021
|
Image does not exist Genes associated with the development of rheumatoid arthritis (Homo sapiens) |
Image does not exist Neuroinflammation and glutamatergic signaling (Homo sapiens) |
Image does not exist Complement system in neuronal development and plasticity (Homo sapiens) |
Image does not exist Fatty acid biosynthesis (Caenorhabditis elegans) |
|
Image does not exist Hepatocyte growth factor receptor signaling (Gallus gallus) |
Image does not exist Hepatocyte growth factor receptor signaling (Pan troglodytes) |
Image does not exist Hepatocyte growth factor receptor signaling (Canis familiaris) |
Image does not exist S1P receptor signal transduction (Canis familiaris) |
May 2021
|
Image does not exist Serine Metabolism (Homo sapiens) |
Image does not exist Peptidoglycan cytoplasmic synthesis and recycling pathways (Escherichia coli) |
Image does not exist FOXA2 pathway (Homo sapiens) |
Image does not exist Modulators of TCR signaling and T cell activation (Homo sapiens) |
|
Image does not exist Kallmann's Syndrome (Homo sapiens) |
Image does not exist Fatty acid transporters (Homo sapiens) |
April 2021
|
Image does not exist FOXP3 in COVID-19 (Homo sapiens) |
Image does not exist SARS-CoV-2 altering angiogenesis via NRP1 (Homo sapiens) |
Image does not exist Soluble ACE2-mediated cell entry of SARS-CoV-2 (Homo sapiens) |
March 2021
|
Image does not exist Hair Follicle Development: Organogenesis - Part 2 of 3 (Homo sapiens) |
Image does not exist Liver steatosis AOP (Homo sapiens) |
Image does not exist nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell (Homo sapiens) |
Image does not exist Kynurenine Pathway and links to Cellular Senescence (Homo sapiens) |
|
Image does not exist NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence (Homo sapiens) |
Image does not exist Nephrogenesis (Homo sapiens) |
Image does not exist Development of ureteric collection system (Homo sapiens) |
Image does not exist 7-oxo-C and 7beta-HC pathways (Homo sapiens) |
February 2021
|
Image does not exist Airway smooth muscle cell contraction (Homo sapiens) |
Image does not exist SARS-CoV-2 mitochondrial interactions (Homo sapiens) |
Image does not exist SARS-CoV-2 Innate Immunity Evasion and Cell-specific immune response (Homo sapiens) |
Image does not exist Glycolysis in senescence (Homo sapiens) |
|
Image does not exist TCA cycle in senescence (Homo sapiens) |
January 2021
|
Image does not exist Mitochondrial fatty acid synthesis pathway (Homo sapiens) |
Image does not exist Ethylmalonic Encephalopathy (Homo sapiens) |
Image does not exist Biotin Metabolism (including IEMs) (Homo sapiens) |
Image does not exist Riboflavin and CoQ disorders (Homo sapiens) |
December 2020
|
Image does not exist Acetogenesis (Acetobacterium woodii) |
Image does not exist RAS and Bradykinin pathways in COVID-19 (Homo sapiens) |
Image does not exist Galanin receptor pathway (Homo sapiens) |
Image does not exist CAMKK2 Pathway (Homo sapiens) |
|
Image does not exist STING pathway in Kawasaki-like disease and COVID-19 (Homo sapiens) |
November 2020
|
Image does not exist Deregulation of the Renin Angiotensin system by Sars-CoV infection (Mus musculus) |
Image does not exist 16p11.2 proximal deletion syndrome (Homo sapiens) |
Image does not exist SARS-CoV-2 and COVID-19 Pathway (Homo sapiens) |
Image does not exist aspirin and miRNAs (Homo sapiens) |
October 2020
|
Image does not exist Glucocorticoid Receptor Pathway (Homo sapiens) |
Image does not exist 7q11.23 copy number variation syndrome (Homo sapiens) |
Image does not exist DNA Repair Pathways Full Network (Homo sapiens) |
Image does not exist 16p11.2 distal deletion syndrome (Homo sapiens) |
|
Image does not exist p53 transcriptional gene network (Homo sapiens) |
Image does not exist Fluoroacetic acid toxicity (Homo sapiens) |
Image does not exist Phosphoinositides metabolism (Homo sapiens) |
September 2020
|
Image does not exist |
Image does not exist |
Image does not exist |
August 2020
|
Image does not exist Beta Oxidation of Unsaturated Fatty Acids (Caenorhabditis elegans) |
July 2020
|
Image does not exist MAPK pathway in congenital thyroid cancer (Homo sapiens) |
Image does not exist 15q11.2 copy number variation syndrome (Homo sapiens) |
Image does not exist Mitochondrial Complex I inhibition leading to chemical induced fanconi syndrome (Homo sapiens) |
Image does not exist NO metabolism in cystic fibrosis (Homo sapiens) |
June 2020
|
Image does not exist EGFR Tyrosine Kinase Inhibitor Resistance (Homo sapiens) |
Image does not exist The influence of laminopathies on Wnt signaling (Homo sapiens) |
Image does not exist Linoleic acid metabolism known to be affected by coronavirus infection (Homo sapiens) |
Image does not exist Endoplasmic reticulum (ER) stress response in Coronavirus infection (Homo sapiens) |
|
Image does not exist SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor: Molecular mechanisms and potential therapeutic target (Homo sapiens) |
Image does not exist LDLRAD4 and what we know about it (Homo sapiens) |
Image does not exist 3q29 copy number variation syndrome (Homo sapiens) |
Image does not exist COVID-19, thrombosis and anticoagulation (Homo sapiens) |
|
Image does not exist Direct Reversal Repair (Homo sapiens) |
May 2020
|
Image does not exist Mitochondrial CIV Assembly (Homo sapiens) |
Image does not exist Autophagy (Homo sapiens) |
Image does not exist Unfolded protein response (Homo sapiens) |
Image does not exist MAP3K1 role in promoting and blocking gonadal determination (Homo sapiens) |
|
Image does not exist Cellular Proteostasis (Homo sapiens) |
Image does not exist Neuroinflammation (Homo sapiens) |
Image does not exist Mitochondrial CII Assembly (Homo sapiens) |
Image does not exist Mitochondrial CIII assembly (Homo sapiens) |
|
Image does not exist Purinergic signaling (Homo sapiens) |
Image does not exist 1q21.1 copy number variation syndrome (Homo sapiens) |
Image does not exist SARS coronavirus and innate immunity (Homo sapiens) |
Image does not exist Proximal tubule transport (Homo sapiens) |
|
Image does not exist Somatic Sex determination (Homo sapiens) |
Image does not exist Peroxiredoxin 2 induced ovarian failure (Homo sapiens) |
Image does not exist Disruption of postsynaptic signalling by CNV (Homo sapiens) |
Image does not exist Interacting Laminopathic Pathways (Homo sapiens) |
|
Image does not exist Peroxiredoxin 2 induced ovarian failure (Mus musculus) |
Image does not exist Mammalian disorder of sexual development (Homo sapiens) |
April 2020
|
Image does not exist Nanomaterial-induced Inflammasome Activation (Homo sapiens) |
Image does not exist Oxidative Stress and Redox Pathway (Mus musculus) |
Image does not exist Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein. (Homo sapiens) |
Image does not exist Ciliopathies (Homo sapiens)) |
|
Image does not exist Cholesterol Biosynthesis with Skeletal Dysplasias (Homo sapiens) |
Image does not exist Endochondral Ossification with Skeletal Dysplasias (Homo sapiens) |
Image does not exist Glycosaminoglycan degradation (Homo sapiens) |
Image does not exist Conversion of Angiotensinogen to Angiotensin II (Homo sapiens) |
|
Image does not exist GDNF/RET signalling axis (Mus musculus) |
Image does not exist Genes controlling renal nephrogenesis (Homo sapiens) |
Image does not exist Regucalcin in proximal tubule epithelial kidney cells (Homo sapiens) |
Image does not exist COVID-19 AOP (Homo sapiens) |
|
Image does not exist Intracellular trafficking proteins involved in CMT neuropathy (Homo sapiens) |
Image does not exist Hijack of Ubiquitination by SARS-CoV-2 (Homo sapiens) |
Image does not exist Host-pathogen interaction of human corona viruses - autophagy (Homo sapiens) |
Image does not exist Host-pathogen interaction of human corona viruses - apoptosis (Homo sapiens) |
|
Image does not exist Type I Interferon Induction and Signaling During SARS-CoV-2 Infection (Homo sapiens) |
Image does not exist Kisspeptin/Kisspeptin Receptor System in the Ovary (Homo sapiens) |
Image does not exist Activation of NLRP3 Inflammasome by SARS-CoV-2 (Homo sapiens) |
Image does not exist Pathogenesis of SARS-CoV-2 Mediated by nsp9/nsp10 Complex (Homo sapiens) |
|
Image does not exist Host-pathogen interaction of human corona viruses - MAPK signaling (Homo sapiens) |
Image does not exist Host-pathogen interaction of human corona viruses - Interferon induction (Homo sapiens) |
March 2020
|
Image does not exist Proteoglycan biosynthesis (Homo sapiens) |
Image does not exist Somitogenesis in the context of spondylocostal dysostosis (Homo sapiens) |
Image does not exist Type I collagen synthesis in the context of Osteogenesis imperfecta (Homo sapiens) |
Image does not exist Osteoblast differentiation (Homo sapiens) |
|
Image does not exist Autosomal recessive Osteopetrosis pathways (Homo sapiens) |
Image does not exist MED and Pseudoachondroplasia genes (Homo sapiens) |
Image does not exist FGF23 signalling in Hypophosphatemic rickets (Homo sapiens) |
Image does not exist mBDNF and proBDNF regulation of GABA neurotransmission (Homo sapiens) |
|
Image does not exist GDNF/RET signalling axis (Homo sapiens) |
February 2020
|
Image does not exist FGFR3 signalling in chondrocyte proliferation and terminal differentiation (Homo sapiens) |
Image does not exist Purine metabolism (Homo sapiens) |
Image does not exist Monoterpene Biosynthesis Pathway Genes in Mint (Homo sapiens) |
January 2020
|
Image does not exist Vitamin D-sensitive calcium signaling in depression (Homo sapiens) |
Image does not exist Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism (Homo sapiens) |
Image does not exist Netrin-UNC5B signaling Pathway (Homo sapiens) |
Image does not exist Base Excision Repair (Homo sapiens) |
|
Image does not exist Nucleotide Excision Repair (Homo sapiens) |
Image does not exist IL-18 signaling pathway (Homo sapiens) |
Image does not exist Renin Angiotensin Aldosterone System (RAAS) (Homo sapiens) |
Image does not exist PKC-gamma calcium signaling pathway in ataxia (Homo sapiens) |
|
Image does not exist Regulation of Pgc1a expression by a Gsk3b-Tfeb signaling axis in skeletal muscle (Mus musculus) |
